Search - tctmd.com

Displaying 161 - 180 of 249

Sort: Relevancy | Date

Presentation TCT 2014

Difficult Primary PCI Decisions

Presenter: George D. Dangas, Ziyad M. Hijazi, Roxana Mehran, Abdullah Shehab

September 16, 2014

Presentation TCT 2014

LpPLA2 Inhibition by Darapladib in Coronary Artery Disease: Game Over or Just Beginning?

Presenter: Ori Ben-Yehuda, Harvey D. White, Roxana Mehran

September 15, 2014

Presentation TCT 2014

Intravenous HDL to Regress Plaque

Presenter: Ori Ben-Yehuda, Harvey D. White, Roxana Mehran

September 15, 2014

Presentation TCT 2014

PCSK9 Inhibitors: Comparison of Agents and a Systematic Review

Presenter: Ori Ben-Yehuda, Harvey D. White, Roxana Mehran, Evan A. Stein

September 15, 2014

Presentation TCT 2014

Innovative Technologies to Reduce and Monitor Contrast Dosage During Angiography

Presenter: Chaim S. Lotan, Julio C. Palmaz, Mark A. Turco, Roxana Mehran

September 15, 2014

Presentation TCT 2014

Statistical and Regulatory Challenges with Big Data and National Registries: Is Propensity Adjustment Enough? FDA Considerations

Presenter: Matthew G. Hillebrenner, Roxana Mehran, Aaron V. Kaplan, Gregory Campbell

September 15, 2014

Presentation TCT 2014

Are We Ready for Radical Changes in Medical Device Clinical Trial Designs?

Presenter: Matthew G. Hillebrenner, Roxana Mehran, Aaron V. Kaplan, Robert M. Califf

September 15, 2014

Presentation TCT 2014

CDRH Efforts to Improve the Ecosystem for Clinical Trials

Presenter: Matthew G. Hillebrenner, Roxana Mehran, Aaron V. Kaplan, Owen Faris

September 15, 2014

Presentation TCT 2014

Keynote Lecture II: Clinical Research in the United States Current Realities and How the Tide Can Turn

Presenter: Matthew G. Hillebrenner, Roxana Mehran, Aaron V. Kaplan, Robert A. Harrington

September 15, 2014

Presentation TCT 2014

SECURITY: A Prospective, Randomized Trial of Six Months Versus 12 Months of Dual Antiplatelet Therapy Following Coronary Drug-Eluting Stent Implantation

Presenter: Roxana Mehran, Harvey D. White, Antonio Colombo

September 15, 2014

Presentation TCT 2014

ISAR-TRIPLE: A Prospective, Randomized Trial of Six Weeks Versus Six Months of Clopidogrel in Patients Treated with Concomitant Aspirin and Oral Anticoagulant Therapy Following Coronary Drug-Eluting Stent Implantation

Presenter: Roxana Mehran, Harvey D. White, Nikolaus Sarafoff

September 15, 2014

Presentation TCT 2014

BRIGHT: A Prospective, Randomized Trial of Bivalirudin Monotherapy Versus Heparin Monotherapy Versus Heparin Plus Tirofiban in Patients with Acute Myocardial Infarction Undergoing Coronary Intervention

Presenter: Roxana Mehran, Harvey D. White, Yaling Han

September 15, 2014

Presentation TCT 2014

The Data Strongly Support Bivalirudin!

Presenter: Roxana Mehran

September 14, 2014

Presentation TCT 2014

Is There a Role for PCI in Revascularization of Diabetic Patients with Multivessel Disease?

Presenter: Roxana Mehran, Mohamed Sobhy, Habib Gamra

September 13, 2014

Presentation TCT 2014

Left Main Disease: Practical Issues When Determining Treatment

Presenter: Roxana Mehran, Mohamed Sobhy, Gennaro Sardella

September 13, 2014

Presentation TCT 2014

Intermediate Syntax Score: PCI vs CABG?

Presenter: Roxana Mehran, Mohamed Sobhy, Davide Capodanno

September 13, 2014

Presentation TCT 2014

Role of New Oral Anticoagulants and New ADP Antagonists in ACS Patients

Presenter: Roxana Mehran, Mohamed Sobhy

September 13, 2014

Presentation TCT 2014

The Informed Consent Process: More Complicated Than Informed!

Presenter: Roxana Mehran, Bernhard Witzenbichler, Somjot S. Brar, Theresa Franklin-Bond

September 13, 2014

Presentation TCT 2014

How to Be a Key Enroller in Clinical Trials: Building the Team!

Presenter: Roxana Mehran, Bernhard Witzenbichler, Somjot S. Brar, James C. Blankenship

September 13, 2014

Presentation TCT 2014

Guiding Principles in Clinical Research: The Essentials (GCP, IRB, Informed Consent, and Quality Assurance)

Presenter: Roxana Mehran, Bernhard Witzenbichler, Somjot S. Brar, Kate Dalton

September 13, 2014

Advertisement

Difficult Primary PCI Decisions

LpPLA2 Inhibition by Darapladib in Coronary Artery Disease: Game Over or Just Beginning?

Intravenous HDL to Regress Plaque

PCSK9 Inhibitors: Comparison of Agents and a Systematic Review

Innovative Technologies to Reduce and Monitor Contrast Dosage During Angiography

Statistical and Regulatory Challenges with Big Data and National Registries: Is Propensity Adjustment Enough? FDA Considerations

Are We Ready for Radical Changes in Medical Device Clinical Trial Designs?

CDRH Efforts to Improve the Ecosystem for Clinical Trials

Keynote Lecture II: Clinical Research in the United States Current Realities and How the Tide Can Turn

SECURITY: A Prospective, Randomized Trial of Six Months Versus 12 Months of Dual Antiplatelet Therapy Following Coronary Drug-Eluting Stent Implantation

ISAR-TRIPLE: A Prospective, Randomized Trial of Six Weeks Versus Six Months of Clopidogrel in Patients Treated with Concomitant Aspirin and Oral Anticoagulant Therapy Following Coronary Drug-Eluting Stent Implantation

BRIGHT: A Prospective, Randomized Trial of Bivalirudin Monotherapy Versus Heparin Monotherapy Versus Heparin Plus Tirofiban in Patients with Acute Myocardial Infarction Undergoing Coronary Intervention

The Data Strongly Support Bivalirudin!

Is There a Role for PCI in Revascularization of Diabetic Patients with Multivessel Disease?

Left Main Disease: Practical Issues When Determining Treatment

Intermediate Syntax Score: PCI vs CABG?

Role of New Oral Anticoagulants and New ADP Antagonists in ACS Patients

The Informed Consent Process: More Complicated Than Informed!

How to Be a Key Enroller in Clinical Trials: Building the Team!

Guiding Principles in Clinical Research: The Essentials (GCP, IRB, Informed Consent, and Quality Assurance)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content